市场调查报告书
商品编码
1209804
全球腹腔镜设备市场:到 2028 年的预测——按产品类型(腹腔镜、吸引器、其他产品类型)、应用(泌尿外科、妇科外科、其他应用)最终用户、地区分析Laparoscopy Instruments Market Forecasts to 2028 - Global Analysis By Product Type (Laparoscopes, Insufflators and Other Product types), Application (Urological Surgery, Gynecological Surgery and Other Application) End User and By Geography |
根据 Stratistics MRC,全球腹腔镜器械市场规模将在 2022 年达到 140.8 亿美元,到 2028 年将达到 317.3 亿美元,在预测期内增长 14.5%。预计将以复合年增长率。
腹腔镜手术是指在照相机的帮助下通过一个或多个小切口而不是腹壁的大(通常是一个)切口进行外科手术的器械。 腹腔镜手术的优点是微创、无痛、不留疤痕。 此外,还具有美容效果、减轻腹壁负担、缩短住院时间、恢復日常生活快、出血少、止血可靠等优点。
根据 Ergie P.Inocian 等人的说法,中东的减肥手术数量正在增加,以解决肥胖和代谢紊乱问题。 因此,减肥手术继续被中东和北非地区接受为治疗严重肥胖症的方法,预计将对市场增长产生积极影响。
市场动态
驱动程序
与开放手术相比,越来越倾向于微创手术
腹腔镜手术具有住院时间短、失血少、并发症少、恢復时间短、疗效好、感染风险低、切口小、疼痛小等优点,是首选,因为它与传统手术相比,它具有许多优势,例如更少的瘀伤。 随着对腹腔镜手术的需求急剧增加,预计在预测期内对腹腔镜手术器械的需求也会扩大。
抑製剂
缺乏训练有素的医疗保健专业人员
腹腔镜手术对医疗助理控制外科医生的可视化提出了挑战。 疲劳、技术错误、完成手术的时间和仪器处理水平都会增加。 由于感染、过敏反应、器官损伤、粘连、血块、内出血和小穿刺导致的运动范围缩小,也可能会很困难。 在某些情况下,不稳定的摄像机平台、有限的运动会抑制市场增长,并且不允许外科医生有效地进行手术。
机会
生活方式的改变
市场增长的动力来自越来越多的患有子宫肌瘤和子宫内膜异位症等健康问题的患者、子宫切除术和子宫切除手术数量的增加以及新兴国家对改善医疗基础设施的意识增强。. 此外,医疗腹腔镜机器人、腹腔镜、腹腔镜可重复使用的微创设备、腹腔镜滑锁抓取器、腹腔镜抽吸冲洗装置和专用腹腔镜设备等设备正在推动市场增长。
威胁
新兴国家对腹腔镜手术的基础设施支持减少
但是,在新兴国家/地区,可用于支持先进医疗实践(例如腹腔镜检查)的基础设施存在重大差距。 新兴国家的医疗保健系统难以提供支持腹腔镜手术等先进手术技术的基础设施和资源,导致这些国家进行的腹腔镜手术数量下降,并阻碍了腹腔镜设备市场的发展。
COVID-19 的影响
COVID-19 大流行已成为全球医疗保健行业面临的重大挑战。 由于获得医疗服务的机会有限,患有其他疾病的患者得不到治疗。 腹腔镜手术受到大流行的影响。 在此期间,手术可能会被取消甚至推迟,以降低病毒的传播速度。 COVID-19 大流行对该地区的泌尿科护理和泌尿科医生招聘产生了重大影响。 大流行期间对医疗保健系统的特殊影响改变了泌尿外科实践,从而减缓了市场增长。
腹腔镜部分预计将成为预测期内最大的部分
由于腹腔镜能够诊断腹部和骨盆内发生的各种情况,因此推测腹腔镜部分有良好的生长。 该手术包括通过切口插入一根小管并通过该管泵送二氧化碳使胃膨胀,疼痛更小,患者更容易处理手术前后的压力,也不太可能引起感染。相信这将推动市场的增长。
手术部分预计在预测期内的复合年增长率最高。
预计减肥手术部分在预测期内将呈现最快的复合年增长率,因为它是治疗肥胖症的主要治疗方法之一。 在这种手术中,胃的一部分被切除或使用胃束带来缩小胃的大小。 世界范围内儿童和青少年的肥胖率不断上升,导致一些年轻患者接受了减肥手术。 减肥手术的增加可能会增加对一次性腹腔镜设备的需求。
市场份额最高的地区
北美预计在预测期内占据最大的市场份额。 促成该地区高速增长的因素包括肥胖症、各种慢性病的增加以及微创手术的日益普及。 此外,美国现有企业在各种手术设备方面的进步可能会推动北美市场的增长。
复合年增长率最高的地区
由于老年人口不断增加以及胃肠道和腹部疾病的流行,预计欧洲在预测期内的复合年增长率最高。 此外,欧洲人病态肥胖发病率的急剧上升可能会增加该地区为减轻体重而进行的减肥手术的需求,从而推动腹腔镜设备的增长。
主要发展
2022 年 12 月,美敦力 (Medtronic) 宣布第一位患者参加了 HUGO(TM) 机器人辅助手术系统的美国临床试验活动,疤痕更小。
2022 年 12 月,Stryker 将推出 Citrefix(TM) 缝合锚系统。 它采用屡获殊荣的 Citregen 生物材料,旨在支持骨骼再生和自然癒合过程。
新系统使用 Citregen(TM),这是一种屡获殊荣的生物可吸收材料,旨在模仿天然骨骼的化学和结构。
2022 年 11 月,美敦力 (Medtronic) 在美国推出全球首款也是唯一一款用于胰岛素泵的输液器,可将佩戴时间延长一倍,长达 7 天输液器是将胰岛素从胰岛素泵输送到体内的管子,因此通常需要更换每 2 到 3 天设置一次。
本报告的内容
免费定制服务
订阅此报告的客户将免费获得以下自定义选项之一。
According to Stratistics MRC, the Global Laparoscopic Instruments Market is accounted for $14.08 billion in 2022 and is expected to reach $31.73 billion by 2028 growing at a CAGR of 14.5% during the forecast period. Laparoscopic Instruments are the instruments that are used for surgical procedures that are performed through one or multiple small incisions, moderately than through a larger, typically single, incision through the abdominal wall with the help of a camera. Laparoscopic Instruments offer benefits of minimal invasion and less pain which heal faster and do not leave scars. Moreover, they provide better cosmesis, reduction in the rate of problems at the abdominal wall, shorter duration of hospitalization, and faster recommencement of daily life activities, use of these devices in surgical procedures ensure minimal bleeding and help in maintaining haemostasis.
According to a Ergie P.Inocian et al., published in Surgery for Obesity and Related Diseases Journal June 2021, there has been an increasing volume of bariatric surgeries in the Middle East to address obesity and metabolic disorders. Thus, bariatric surgical procedures continue to gain acceptance as a treatment for severe obesity in the Middle-East and North Africa regions, which is expected to impact market growth positively.
Market Dynamics:
Driver:
Rising inclination towards minimal invasive surgery over open surgery
The laparoscopic surgery is preferred more than usual surgeries owing to its abundant benefits, such as shorter hospital stay, decreased blood loss, and lower patient morbidity of laparoscopy, as well as providing quick recovery time, rapid and successful outcomes, low risk of infection, small or no incision and less pain. As the demand for laparoscopic surgery is drastically increasing, the demand for laparoscopic instruments is likely to also grow during the forecast period.
Restraint:
Lack of trained healthcare professionals
Laparoscopic surgery challenges the medical assistant control of surgeon visualization. There are increased levels of fatigue, technical errors, time to complete the surgery and instrument handling. This can also include infection, allergic reactions, damage to the organs, adhesions, blood clots, internal bleeding, in addition due to the reduced range of movement from tiny holes can be difficult. In some cases the unstable video camera platform, limited motion does not allow the surgeon to perform the surgery effectively, thus hampering the market growth.
Opportunity:
Change in lifestyle patterns
The factors driving the growth of the market are the increasing number of patients suffering from health issues such as uterine fibroids, and endometriosis, the rising number of hysterectomy and myomectomy procedures, and growing awareness about the improving healthcare infrastructure in emerging economies. Moreover instruments like medical laparoscopic robots, laparoscopes, laparoscopy reusable minimally invasive instruments, laparoscopic slide lock graspers, laparoscopic suction irrigation sets, and specialty laparoscopic instruments are propelling the market growth.
Threat:
Diminished infrastructure support for laparoscopic procedures in developing countries
However developing countries have a wide gap in the infrastructure available to support advanced medical procedures such as laparoscopy. The healthcare systems in developing countries are struggling to provide the infrastructure and resources to support advanced surgical techniques such as laparoscopic procedures which in turn reduces the number of laparoscopic procedures performed in these countries there by hindering the laparoscopic instruments market.
COVID-19 Impact
The COVID-19 pandemic has produced a significant challenge for the global healthcare industry. The Restricted access to medical services has led to insufficient care for patients suffering from other diseases. Laparoscopy has been adversely impacted by the pandemic. During this period, surgeries are often even cancelled or being postponed to the lower transmission of the virus. The COVID-19 pandemic has significantly impacted urological care and urologist recruitment in this region. The urology practice has been changed due to the exceptional impact on the healthcare system during the pandemic, hence reducing the market growth.
The Laparoscopes segment is expected to be the largest during the forecast period
The Laparoscopes segment is estimated to have a lucrative growth, due to its ability to diagnose a wide range of conditions that develop inside the abdomen or pelvis in which a small tube is inserted through the incision and carbon dioxide gas is pumped through the tube to inflate the stomach and performed as this procedure is less painful and easy for the patient to handle the pre and post operational stress with minimal infectious conditions are boosting the growth of the market.
The surgery segment is expected to have the highest CAGR during the forecast period
The bariatric surgery segment is anticipated to witness the fastest CAGR growth during the forecast period because it is one of the major treatment procedures for treating obesity. During this procedure, the size of the stomach is reduced by either removing some parts of the stomach or using a gastric band. Increasing obesity rates among children and adolescents are being witnessed across the globe, leading to several young patients undergoing bariatric surgery. The increasing bariatric surgical procedures are likely to raise the demand for disposable laparoscopic devices.
Region with highest share:
North America is projected to hold the largest market share during the forecast period owing to The factors attributed to the region's high growth are the increasing cases of obesity, various chronic diseases, and the growing adoption of minimally-invasive surgeries. the high prevalence of chronic diseases in the country increases the demand for minimally invasive surgeries, thus, driving the laparoscopy devices market. Furthermore, advancements in various surgical devices from established players in the US are likely to drive market growth in North America.
Region with highest CAGR:
Europe is projected to have the highest CAGR over the forecast period, owing to increase in geriatric population and prevalence of gastrointestinal & abdominal diseases in the region. In addition, rush in incidences of morbid obesity among the European population is likely to increase the demand for bariatric surgeries performed in the region for reducing weight, thereby boosting the growth of laparoscopy devices.
Key players in the market
Some of the key players profiled in the Laparoscopic Instruments Market include Medtronic, Stryker Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, CONMED Corporation, GENICON, INC., Karl Storz SE & CO., Johnson and Johnson, Applied Medical Resources Corporation, Microline Surgical, Mediflex-surgical-products.
Key Developments:
In Dec 2022, Medtronic announces first patient enrolled in U.S. clinical trial for Hugo™ robotic-assisted surgery system e robotic-assisted prostatectomy procedure was performed by Dr. Michael R. Abern at Duke University Hospital in Durham, N.C. Minimally invasive surgery, including robotic-assisted surgery, offers fewer complications, shorter hospital stays, faster return to normal activities, and smaller scars.
In Dec 2022, Stryker launches Citrefix™ Suture Anchor System, featuring award-winning Citregen biomaterial designed to support bone regeneration and the natural healing process
The new system uses Citregen™, an award-winning bioresorbable material designed to mimic the chemistry and structure of native bone.
In Nov 2022, Medtronic Launches World's First and Only Infusion Set for Insulin Pumps that Doubles Wear Time up to 7 days in U.S.e. An infusion set is tubing that delivers insulin from an insulin pump to the body and typically requires a set change every two to three days.
Product Types Covered:
Applications Covered:
End Users Covered:
Regions Covered:
What our report offers:
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options: